SPY765.67QQQ737.84+0.18%BTC/USD84,111.68+0.78%DIA513.51−0.10%GLD380.49+0.68%TLT78.63+0.01%
Benzinga

4D Molecular Therapeutics Inc (FDMT) Stock Price, Quote, News & History

FDMTNASDAQ
Trade with Public
Trade with Public
$14.56
0.090.62%
At close: Sep 25, 5:00 PM EST
$14.55
0.080.55%
Pre-Market: 4:25 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

4D Molecular Therapeutics (FDMT) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$14.56
Volume / Avg.
314.00 / 949.36K
Day Range
- - -
52 Wk Range
6.96 - 16.93
Market Cap
$803.80M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
24.92%
Days to Cover
18.55

Recent 4D Molecular Therapeutics Inc News

Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures rose, but Scholastic plunged 9.9% after missing Q1 loss and sales estimates; several other stocks also fell premarket.
Avi Kapoor

This Coinbase Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

Analysts upgraded Coinbase, 4D Molecular Therapeutics, Affirm, Chime Financial and Bullish, raising ratings and price targets.
Avi Kapoor

4D Molecular's One-Shot Eye Therapy Delivers Two-Year Win

4D Molecular Therapeutics reports positive 2-year Phase 2b data for 4D-150 in wet AMD, showing up to an 87% cut in treatment burden.
Vandana Singh

BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

Jim Cramer: AppLovin Calls For Prudence, This Health Care Stock Is 'Pure Spec'

Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent," he said.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-156.07M
Investing Cash Flow (TTM)
-16.64M
Financing Cash Flow (TTM)
165.92M
Free Cash Flow (TTM)
-155.97M
Capital Expenditure (TTM)
106.00K
Net Change in Cash (TTM)
-6.79M

Analyst Trends and Forecast

1
Mar
2
Jul
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$483.34M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
10.24
PB Ratio (TTM)
1.98
Earnings Yield % (TTM)
-18.04%
Earnings Yield % (FWD)
-30.28%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$7.38

Company Debt

Total Debt
$19.59M
LT Debt
$19.59M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$70.37M
Debt to Equity
0.10
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$14.56
Volume / Avg.
314.00 / 949.36K
Day Range
- - -
52 Wk Range
6.96 - 16.93
Market Cap
$803.80M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
24.92%
Days to Cover
18.55

About

Sector
Health Care
Industry
Biotechnology
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy 4D Molecular Therapeutics (FDMT) stock?

A

You can purchase shares of 4D Molecular Therapeutics (NASDAQ:FDMT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are 4D Molecular Therapeutics (FDMT) competitors?

Q

What is the forecast, or price target, for 4D Molecular Therapeutics (FDMT) stock?

A

4D Molecular Therapeutics has a consensus price target of $33.06.

Q

What is the current price for 4D Molecular Therapeutics (FDMT)?

A

The stock price for 4D Molecular Therapeutics (NASDAQ: FDMT) is $14.55 last updated September 29, 2026 at 4:17 AM EDT.

Q

Does 4D Molecular Therapeutics (FDMT) pay a dividend?

A

There are no upcoming dividends for 4D Molecular Therapeutics.

Q

When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?

A

4D Molecular Therapeutics does not have any upcoming earnings scheduled.

Q

Is 4D Molecular Therapeutics (FDMT) going to split?

A

There is no upcoming split for 4D Molecular Therapeutics.

Q

What sector and industry does 4D Molecular Therapeutics (FDMT) operate in?

A

4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved